Comment from Alliance for Regenerative Medicine

Summary: The Alliance for Regenerative Medicine (ARM) supports the development of master protocols to accelerate drug development, particularly for rare diseases. They provide specific recommendations to clarify the guidance regarding biomarkers, trial designs for cellular and gene therapies, and IND cross-referencing.